Lv2
150 积分 2025-03-18 加入
Future treatments for myelin oligodendrocyte glycoprotein antibody-associated disease: the clinical trial landscape
2天前
已完结
Should We test for IgG Antibodies Against MOG in Both Serum and CSF in Patients With Suspected MOGAD?
2天前
已完结
Evolution of brain MRI lesions in paediatric myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and its relevance to disease course
2天前
已完结
Clinical feature and disease outcome in patients with myelin oligodendrocyte glycoprotein antibody-associated disorder: a Chinese study
2天前
已完结
Anti-HLA serological response to CD38-targeting desensitization therapy is challenged by peripheral memory B-cells in highly sensitized kidney transplant candidates
20天前
已完结
Acute eculizumab treatment in a pediatric patient with AQP4-IgG+ NMOSD
1个月前
已完结
Hope for patients with neuromyelitis optica spectrum disorders — from mechanisms to trials
1个月前
已完结
Effects of immunoadsorption combined with membrane filtration on complement markers – results of a randomized, controlled, crossover study
1个月前
已完结
Unveiling Disability Accrual Mechanisms in AQP4-IgG–Positive NMOSD
1个月前
已完结
ECTRIMS 2024 Lecture: Unraveling the spectrum of the antibody-mediated demyelinating diseases: Emerging insights
1个月前
已完结
皖公网安备34019202002308
